Pharma: Page 43
-
HealthTech
Walmart Acquires Telehealth Company MeMD Trend Watch: Major Retailers Walmart and Amazon Face Off in Telehealth Services Walmart Acquires Telehealth Company MeMD Walmart Health is buying multi-specialty telehealth provider MeMD, which will enable the company to expand its Walmart Health services ...
By PharmaVoice Team • June 1, 2021 -
Upfront
AstraZeneca Sponsors USA Science & Engineering Festival’s X-STEM AstraZeneca is committed to developing the next generation of scientists, engineers, and clinicians through national and global STEM education programs. Empowering students to investigate careers in STEM is crucial for future sc...
By PharmaVoice Team • May 1, 2021 -
Explore the Trendline➔
Stock via Getty ImagesTrendlineCommercialization, marketing and social media
As the pharma industry stares down a historic patent cliff, macroeconomic headwinds and challenging R&D costs for increasingly complex medicines, nailing the launch of new medicines has become increasingly critical.
By PharmaVoice staff -
HealthTech
Amazon Care Expands Reach Trend Watch: COVID-19 Forces Healthtech Innovations from Robots to Partnerships Amazon.com Inc. has rolled out its internal Amazon Care program as a workplace benefit to employers across the country, along with all its U.S. employees beyond its Washington base. Amazon is...
By PharmaVoice Team • May 1, 2021 -
Upfront
Astellas Oncology Fifth Annual C3 Prize Winners Astellas Oncology has named the winners of its 5th Annual C3 Prize(Changing Cancer Care), a global challenge that sparks cancer care innovations beyond medicine to advance ideas that make a big impact in the cancer community. The program awards up t...
By PharmaVoice Team • April 1, 2021 -
HealthTech
Robots Measure Vitals to Minimize Interactions with COVID Patients Trend Watch: COVID-19 Forces Healthtech Innovations from Robots to Partnerships Researchers at Simon Fraser University in Canada have developed three different robots that can sense and measure patients’ healthcare parameters, inc...
By PharmaVoice Team • April 1, 2021 -
Commanders & Chiefs: Biopharma Chief Executive Officers
CEOs of biopharma organizations face unprecedented challenges as they lead their companies amid a global pandemic, shoring up their organizations during turmoil, and learning valuable lessons along the way. David Lucchino Maintaining an Entrepreneurial Edge Over the past year, we have put signifi...
By PharmaVoice Team • Jan. 1, 2021 -
Q&A
Last Word
Six Keys to Beating the Odds and Achieving Startup Success Sharon Cunningham, Co-founder and CEO of Shorla Pharma, details the six steps she and her partner undertook to launch a successful biopharma company. PV: What was it like starting up Shorla Pharma? Cunningham: Starting your own c...
By Sharon Cunningham • Nov. 16, 2020 -
Age of the Machine: The Expanded Role of AI in Pharma
AI and machine learning have the potential to transform the life-sciences industry, but barriers around implementation, process, and regulatory uncertainty must be overcome first. Artificial intelligence and machine learning are very much part of the pharmaceutical landscape today and are expecte...
By Kim Ribbink • Nov. 16, 2020 -
Breaking Glass: Driving Diversity, Equity, and Inclusion
As companies grapple with an emotional year in terms of the pandemic and racial inequality, efforts to address diversity and inclusion are gaining momentum. When Joe Biden and Kamala Harris won the 2020 U.S. presidential election, it signaled a huge leap forward for diversity: the first woman Vic...
By Kim Ribbink • Nov. 16, 2020 -
Commanders & Chiefs: Chief Experience Officers
Chief experience officers are influencing the strategic direction of their companies to address the needs and wants of their customers. Julie Adrian Customer Focus “Get closer than ever to your customers. So close that you tell them what they need well before they realize it themselves." This quo...
By PharmaVoice Team • Nov. 16, 2020 -
PharmaVOICE 100 Who's on the List - By Category
Who’s on the List — 2020 Indexed by Category Commanders & Chiefs Sagar Anisingaraju Saama Technologies Teresa Bitetti Takeda Pharmaceutical Company Olivier Chateau Health Union Dan Chichester Ogilvy Health Jim Corrigan ERT Dr. Jayson Dallas. Aimmune Therapeutics Dr. Eric Dube. Retrophin Dawn ...
By PharmaVoice Team • Aug. 1, 2020 -
Innovators
These visionary thinkers are driving forward-thinking around new processes, new technologies, and new business models. Omni-channel Innovator Raising the bar… by challenging the status quo Jose Ferreira Title: SVP, Product and Innovation Company: CMI Media Industry Awards: Keynote speaker at eMet...
By PharmaVoice Team • Aug. 1, 2020 -
Good Reads: On The Book Shelf
What are they reading? The PharmaVOICE 100 are curious and always in pursuit of continual learning to expand their knowledge and hone their leadership skills. This is sampling of their reading list. Download PDF
By PharmaVoice Team • Aug. 1, 2020 -
2020 Red Jacket Honorees
Inspiring Leaders for Today and Tomorrow Since launching the Red Jacket Award in 2014, PharmaVOICE has recognized 40 inspiring, innovative, collaborative, and transformative individuals who epitomize leadership for today and tomorrow. Red Jacket honorees have raised the bar in terms of what it me...
By PharmaVoice Team • Aug. 1, 2020 -
Red Jacket Al Altomari
A Value-Based Leader Al Altomari Title: Chairman and CEO Company: Agile Therapeutics Awards/Honors: Hall of Fame Father Judge High School, 2017; Hall of Fame, Drexel 100, 2017; CEO of the Year, Finance Magazine, 2016; Father of the Year, American Diabetes Association, 2015; CEO of the Year, New J...
By Al Altomari • Aug. 1, 2020 -
Red Jacket Sharon Callahan
A Call to Action Raising the bar… by calling people to take action Sharon Callahan Title: CEO Company: CDM Personal awards: Healthcare Businesswomen’s Association (HBA) STAR, 2006; PharmaVOICE 100, 2020 (Red Jacket), 2019, 2017; MedAdNews, Industry Person of the Year, 2019; HBA Woman of the Year,...
By Sharon Callahan • Aug. 1, 2020 -
Red Jacket Dr. Nancy A. Dreyer
Shaping the Future of Real-World Evidence Raising the bar… with the help of others Nancy Dreyer, Ph.D. Title: Chief Scientific Officer and Senior VP Company: IQVIA Industry Awards: 2019 Author of the Year, DIA Inspire Award Associations: Drug Information Association; International Society of Pha...
By Dr. Nancy A. Dreyer • Aug. 1, 2020 -
Red Jacket Barry Greene
Every Single Patient Matters Raising the bar… by bringing interconnectivity into everything we do Barry Greene Title: President Company: Alnylam Pharmaceuticals Awards/Honors: Albert Einstein Award; 2008 Pharmaceutical Executive 45 Under Forty Five; 2008 The 11th Annual Myer Saxe Award from the ...
By Barry Greene • Aug. 1, 2020 -
Red Jacket Julie Ross
Steering Toward the Quantum Leap Raising the bar… by constantly challenging the status quo Julie Ross Title: President Company: Advanced Clinical Industry Awards: 2019 Healthcare Businesswomen’s Association’s Chair Award; 2016, 2014 PharmaVOICE 100 Company Awards: 2019 Outstanding Leader; 2018 Ou...
By Julie Ross • Aug. 1, 2020 -
Letter from the Editor
Raising the bar … Last month, I noted that the life-sciences industry has the opportunity to be extraordinary amidst the continuing global pandemic. As we continue to mourn the mounting losses attributed to this global crisis, I am heartened to see how people from companies of all sizes and types...
By Taren Grom • June 1, 2020 -
Letter from the Editor
The Road Ahead As we head into 2020, closing out a decade punctuated by an ever-changing healthcare dynamic shaped by scientific discoveries, technological breakthroughs, innovation at every level, as well as global geopolitical forces, there is no doubt that the status quo is no longer a busines...
By Taren Grom • Jan. 1, 2020 -
Small Pharma Driving Big Pharma Innovation
The Path to R&D Innovation Lies in the Power of Small Pharma Visionary thought leaders such as Bernard Munos of InnoThink and the Milken Institute and Paul Stoffels, M.D., vice chairman of the executive committee and chief scientific officer, Johnson & Johnson, have been advocating for ye...
By Robin Robinson • Jan. 1, 2020 -
SHOWCASE: High-Science Brands: Making Connections for High Science Brands
The growth of high-science brands has changed the life sciences landscape, and with it the strategies companies need to develop to market their products must also undergo a significant shift. Cancer immunotherapies as well as other high-science brands will account for $34 billion in sales by 2024...
By PharmaVoice Team • Jan. 1, 2020 -
High-Science Storytelling: Cracking the Code on Meaningful Messaging
In full transparency, I am a high-science geek. I am jazzed by data, by new technologies and pathways, but most importantly, I am particularly motivated when I have the ability to work on clinically meaningful advancements that truly make a difference in patients’ lives. I am the one in the crowd...
By Amy Graham • Jan. 1, 2020 -
After Approval, Can Gene Therapies Achieve Marketing Success?
Having a well-designed plan that addresses the needs of all stakeholders — patients and their families, medical institutions, payers and manufacturers — will help drive successful outcomes. The advent of gene therapy — personalized medicine reflecting the potential to minimize or cure disease — i...
By Denise Myshko • Nov. 19, 2019